Cargando…
Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo
Hepatocellular carcinoma (HCC) is one of the most malignant cancers and the treatment options for this disease are limited and generally not effective. ROCK has been reported to be highly expressed in many cancer types and its inhibitor Fasudil has shown anti-cancer potential. However, its high toxi...
Autores principales: | Zhao, Ying, Zhang, Yu, Vazirinejad Mehdiabad, Milad, Zhou, Ke, Chen, Yuyuan, Li, Lei, Guo, Jun, Xu, Chuanrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776396/ https://www.ncbi.nlm.nih.gov/pubmed/31581236 http://dx.doi.org/10.1371/journal.pone.0223232 |
Ejemplares similares
-
Peptide-Coated Liposomal Fasudil Enhances Site Specific
Vasodilation in Pulmonary Arterial Hypertension
por: Nahar, Kamrun, et al.
Publicado: (2014) -
Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo
por: Yang, Tan, et al.
Publicado: (2014) -
Mild Hyperthermia Responsive Liposomes for Enhanced In Vitro and In Vivo Anticancer Efficacy of Doxorubicin against Hepatocellular Carcinoma
por: Rahim, Muhammad Abdur, et al.
Publicado: (2021) -
Transferrin-Modified Triptolide Liposome Targeting Enhances Anti-Hepatocellular Carcinoma Effects
por: Zhao, Xiaoli, et al.
Publicado: (2023) -
Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo
por: Li, Weijie, et al.
Publicado: (2019)